Ivermectin

Status: Parasyte Menegioma Clinical Trial

Introduction

"Ivermectin has long been known as a well-documented anti-parasitic drug. Over the past few years, increasing numbers of studies have indicated that ivermectin might have extensive uses as an anticancer agent for the treatment of different types of cancers, such as glioblastoma, breast cancer, ovarian cancer, leukaemia and neurofibromatosis type 2 (NF2) tumours."

Ivermectin is a treatment for "Strongyloidiasis is an underdiagnosed and preventable life-threatening disease caused by infection with the helminth Strongyloides stercoralis. Chronic asymptomatic infection can be sustained for decades, and immunosuppression can lead to disseminated infection, with a mortality rate of 70% - 100%. In the neurosurgical population, corticosteroids are the most consistent cause of hyperinfection."^[1]

"What is strongyloidiasis?

"Strongyloidiasis is an infection with Strongyloides, a parasitic worm. It's sometimes called Strongy. The worm gets into your body through your skin and makes its way to your lungs and intestines, where it matures and reproduces.

Some infections can last for years. It can cause skin or digestive symptoms that come and go (intermittent) or no symptoms at all. If you have a weakened immune system, strongyloidiasis can be life-threatening."^[2]

Lawsuit

Several level firms across the United States are aiding in legel suit claims.

Sources

1. Liu, Jian, et al. "Progress in understanding the molecular mechanisms underlying the antitumour effects of ivermectin." Drug design, development and therapy (2020): 285-296.
   https://www.tandfonline.com/doi/full/10.2147/DDDT.S237393#abstract
2. FDA."Ivermectin and COVID-19" https://www.fda.gov/consumers/consumer-updates/ivermectin-and-covid-19
3. Carpio, Arturo, et al. "Parasitic diseases of the central nervous system: lessons for clinicians and policy makers." Expert review of neurotherapeutics 16.4 (2016): 401-414. https://www.tandfonline.com/doi/full/10.1586/14737175.2016.1155454#d1e884
4. Dominguez, Victor Rodriguez, et al. "Strongyloides hyperinfection syndrome due to corticosteroid therapy after resection of meningioma: illustrative case." Journal of Neurosurgery: Case Lessons 4.2 (2022). https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/4/2/article-CASE21667.xml
5. Cleveland Clinic. "What is strongyloidiasis?" (Last Seen: 12/02/24) https://my.clevelandclinic.org/.../14074-strongyloidiasis
6. Seegerweiss. "Depo-Provera Brain Tumor Lawsuit" https://www.seegerweiss.com/.../depo-provera-brain... /...
7. Khan, Md Saiful Islam, et al. "Ivermectin treatment may improve the prognosis of patients with COVID-19." Archivos de bronconeumologia 56.12 (2020): 828. https://pmc.ncbi.nlm.nih.gov/articles/PMC7837160/